BIOxHEAL
Asset
Placental-derived amniotic membrane allograft providing structural ECM and regenerative factors to promote wound healing
- Stage
- Phase 3
- Modality
- Other
- Target
- Not known
- 3
- Indications
- 1
- Trial
- 1
- Developer
Indications
3Amniotic membrane placental allograft
Phase 3, Recruiting, NCT07852338, clinicaltrials.gov, 7 Oct 2026
Biologic
Phase 3, Recruiting, NCT07852338, clinicaltrials.gov, 7 Oct 2026
Diabetic foot ulcer
Phase 3, Recruiting, NCT07852338, clinicaltrials.gov, 7 Oct 2026
In the full profile
- Owner and partners1
- Trials1
- Signals1
Every asset’s record: target, stage, trials and the evidence behind it.